From Phenotype to Treatment Plan: A Stepwise Clinical Approach to Moderate-Severe Major Depressive Disorder with Suicidal Ideation in High-Functioning Adult Patient
Clicks: 2
ID: 312110
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #386 of 395 articles by views in Social Sciences & Humanity Research Review
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 395 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Major depressive disorder (MDD) represents a significant public health concern, characterized by high rates of morbidity and functional impairment. This detailed case study provides an in-depth analysis of the assessment, diagnostic formulation, and treatment planning for a 34-year-old female presenting with a classic constellation of depressive symptoms. The patient, reported a three-month history of persistent dysphoria, pervasive anhedonia, neurovegetative disturbances (insomnia, appetite/weight loss, fatigue), and cognitive impairments, alongside passive suicidal ideation. A standardized assessment protocol, incorporating the Patient Health Questionnaire-9 (PHQ-9) and the Beck Depression Inventory (BDI), confirmed symptoms of moderate to severe intensity. Following a structured clinical interview and risk assessment, a primary diagnosis of MDD, single episode, moderate severity (ICD-10: F32.1) was established, with a comorbid provisional diagnosis of generalized anxiety disorder (GAD). This paper delineates an integrated, biopsychosocial treatment plan formulated for the patient. The intervention strategy synergistically combines pharmacotherapy (initiation of the SSRI sertraline), evidence-based psychotherapy (a 16-week protocol of Cognitive-Behavioral Therapy), and targeted lifestyle modifications. The rationale for each treatment modality is explored within the context of current clinical guidelines and the patient’s specific presentation. Explicit short-term (1-2 month) and long-term (3-6 month) therapeutic goals are defined, alongside a structured plan for monitoring, safety management, and psychoeducation. The discussion concludes with a prognostic evaluation, emphasizing that consistent adherence to this multimodal framework is associated with a positive outlook for significant symptom remission and functional recovery, while also highlighting the critical importance of relapse prevention strategies in ensuring sustained mental well-being.
| Reference Key |
imported_1776681079_69e6007782c5b
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Dr. Arooj Zahra Rizvi |
| Journal | Social Sciences & Humanity Research Review |
| Year | 2025 |
| DOI |
10.63468/sshrr.301
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.